$326 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 23 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 57.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | QUIDELORTHO CORP | $13,968,462 | -31.3% | 191,244 | -22.1% | 4.29% | -71.4% | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $13,680,598 | -49.0% | 1,638,395 | -18.7% | 4.20% | -78.7% |
| AGEN | Sell | AGENUS INC | $2,392,168 | -51.1% | 2,116,963 | -30.7% | 0.73% | -79.6% |
| IMMP | Sell | IMMUTEP LTDsponsored ads | $981,217 | -48.0% | 516,430 | -42.3% | 0.30% | -78.4% |
| OPK | Sell | OPKO HEALTH INC | $720,902 | -92.2% | 450,564 | -89.4% | 0.22% | -96.7% |
| VTNR | Sell | VERTEX ENERGY INC | $112,585 | -82.1% | 25,300 | -74.8% | 0.04% | -92.4% |
| Sell | OMEGA THERAPEUTICS INC | $107,500 | -90.3% | 50,000 | -74.7% | 0.03% | -96.0% | |
| Sell | MINK THERAPEUTICS INC | $40,588 | -61.7% | 36,898 | -26.9% | 0.01% | -84.6% | |
| TQQQ | Exit | PROSHARES TRultrapro qqq | $0 | – | -70,000 | -100.0% | -0.30% | – |
| Exit | OPKO HEALTH INCcall | $0 | – | -236,800 | -100.0% | -0.38% | – | |
| PLTR | Exit | PALANTIR TECHNOLOGIES INCcl a | $0 | – | -36,700 | -100.0% | -0.42% | – |
| SGRY | Exit | SURGERY PARTNERS INC | $0 | – | -15,000 | -100.0% | -0.50% | – |
| Exit | FIBROGEN INCcall | $0 | – | -277,000 | -100.0% | -0.55% | – | |
| AXDX | Exit | ACCELERATE DIAGNOSTICS INC | $0 | – | -1,510,654 | -100.0% | -0.90% | – |
| Exit | MIRATI THERAPEUTICS INCcall | $0 | – | -50,000 | -100.0% | -1.33% | – | |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -41,377 | -100.0% | -1.93% | – |
| Exit | BLUEPRINT MEDICINES CORPcall | $0 | – | -64,500 | -100.0% | -3.00% | – | |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -152,600 | -100.0% | -4.06% | – |
| Exit | SURGERY PARTNERS INCcall | $0 | – | -175,000 | -100.0% | -5.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.